Add-On Payments for New
Medical Services and Technologies Paid Under the Inpatient
Prospective Payment System (IPPS) (CMS-10638)
Revision of a currently approved collection
No
Regular
09/20/2023
Requested
Previously Approved
36 Months From Approved
11/30/2023
62
62
1,655
1,655
0
0
Sections 1886(d) (5) (K) and (L) of
the Act establish a process of identifying and ensuring adequate
payment for new medical services and technologies (sometimes
collectively referred to in this section as ‘‘new technologies’’)
under the IPPS. Section1886(d)(5)(K)(vi) of the Act specifies that
a medical service or technology will be considered new if it meets
criteria established by the Secretary after notice and opportunity
for public comment. Section 1886(d)(5)(K)(ii)(I) of the Act
specifies that a new medical service or technology may be
considered for new technology add-on payment if, ‘‘based on the
estimated costs incurred with respect to discharges involving such
service or technology, the DRG prospective payment rate otherwise
applicable to such discharges under this subsection is
inadequate.’’ The regulations at 42 CFR 412.87 implement these
provisions and specify three criteria for a new medical service or
technology to receive the additional payment: (1) The medical
service or technology must be new; (2) the medical service or
technology must be costly such that the DRG rate otherwise
applicable to discharges involving the medical service or
technology is determined to be inadequate; and (3) the service or
technology must demonstrate a substantial clinical improvement over
existing services or technologies.
US Code:
42
USC 1395ww Name of Law: Add-On Payments for New Medical
Services and Technologies Policy
The total hourly burden for all
the applicants to fill out and answer questions for their
applications will remain the same at 1,655 hours. This includes a
total of 1,280 hours for applications on the traditional pathway
and 375 hours for those in the alternative pathway. For FY 2025, we
are updating the NTAP MEARIS™ application to further simplify or
clarify existing application questions, including: a) reorganizing
the Coding, Cost, and Volume sections of the application to improve
flow, b) simplifying the FDA section questions and revising
language for these questions to reflect policy changes effective
for FY 2025, c) simplifying the way applicants can include codes
and MS-DRGs, and d) adding additional explanatory notes in multiple
sections of the application to improve understanding of the
question. These changes will not result in any net increase in
burden for applicants.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.